Ocular Technologies SARL Report issue

For profit Phase 3
Founded: Epalinges Switzerland (2012)
Status: Acquired by Sun Pharmaceuticals (2016)

Organization Overview

First Clinical Trial
2014
NCT02254265
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree